4-((4-(5-Chlorothiophen-2-yl)-5-methylpyrimidin-2-yl)amino)-N-(3-morpholinopropyl)benzamide

ID: ALA5188403

Chembl Id: CHEMBL5188403

PubChem CID: 168279011

Max Phase: Preclinical

Molecular Formula: C23H26ClN5O2S

Molecular Weight: 472.01

Names and Identifiers

Canonical SMILES:  Cc1cnc(Nc2ccc(C(=O)NCCCN3CCOCC3)cc2)nc1-c1ccc(Cl)s1

Standard InChI:  InChI=1S/C23H26ClN5O2S/c1-16-15-26-23(28-21(16)19-7-8-20(24)32-19)27-18-5-3-17(4-6-18)22(30)25-9-2-10-29-11-13-31-14-12-29/h3-8,15H,2,9-14H2,1H3,(H,25,30)(H,26,27,28)

Standard InChI Key:  SYCDHCVGJRUHKE-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5188403

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 472.01

Molecular Weight (Monoisotopic): 471.1496

AlogP: 4.36

#Rotatable Bonds: 8

Polar Surface Area: 79.38

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.01

CX Basic pKa: 7.01

CX LogP: 4.20

CX LogD: 4.05

Aromatic Rings: 3

Heavy Atoms: 32

QED Weighted: 0.47

Np Likeness Score: -1.92

References

1. Galal KA, Truong A, Kwarcinski F, de Silva C, Avalani K, Havener TM, Chirgwin ME, Merten E, Ong HW, Willis C, Abdelwaly A, Helal MA, Derbyshire ER, Zutshi R, Drewry DH..  (2022)  Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial PfGSK3/PfPK6 with Activity against Blood Stage Parasites In Vitro.,  65  (19.0): [PMID:36166733] [10.1021/acs.jmedchem.2c00996]

Source

Source(1):

• Scientific Literature